Presurgical somatostatin receptor ligand treatment does not affect tumor consistency in GH-secreting pituitary macroadenomas

PURPOSE: To evaluate whether presurgical treatment using long-acting somatostatin receptor ligands (SRL) may change pituitary tumor consistency and improve surgical outcome in GH-secreting pituitary macroadenomas. METHODS: Retrospective study of 40 patients with GH-secreting pituitary macroadenomas...

Descripción completa

Detalles Bibliográficos
Autores principales: Araujo-Castro, Marta, Pian, Héctor, Ruz-Caracuel, Ignacio, Acitores Cancela, Alberto, Pascual-Corrales, Eider, Rodríguez Berrocal, Víctor
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bioscientifica Ltd 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7923129/
https://www.ncbi.nlm.nih.gov/pubmed/33289697
http://dx.doi.org/10.1530/EC-20-0414

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7923129/
https://www.ncbi.nlm.nih.gov/pubmed/33289697
http://dx.doi.org/10.1530/EC-20-0414

Ejemplares similares